Speaker Profile

Ph.D., Chief Scientific Officer, Foundation Medicine

Biography
Dr Hegde is responsible for diagnostic product development and innovation in next generation technologies. Prior to joining FMI, she spent 14 years at Genentech as head of the clinical translational science and biomarker efforts for Cancer Immunotherapy. She received her postdoctoral education in genomics from The Institute for Genomic Research (TIGR) and graduate education from SUNY, Buffalo.


 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative